FDA Approves NovoLog(R) Category Change For Use In Pregnant Women With Type 1 Diabetes

... Novo Nordisk announced today that the United States Food and Drug Administration (FDA) has approved NovoLog(R) (insulin aspart [rDNA origin] injection) for pregnancy Category B rating, further validating NovoLog(R) as a safe and effective treatment for pregnant women with Type 1 diabetes and their unborn children. [click link for full article] ...